Steven Seedhouse
Stock Analyst at Cantor Fitzgerald
(4.56)
# 1,008
Out of 4,698 analysts
332
Total ratings
45.5%
Success rate
11.7%
Average return
Main Sectors:
Stocks Rated by Steven Seedhouse
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IRD Opus Genetics | Maintained: Buy | $15 | $4.12 | +264.08% | 5 | Aug 21, 2026 | |
| INVA Innoviva | Maintained: Buy | $34 | $21.00 | +61.90% | 7 | Aug 21, 2026 | |
| EYPT EyePoint | Downgraded: Hold | n/a | $5.40 | - | 3 | Aug 17, 2026 | |
| PRQR ProQR Therapeutics | Maintained: Buy | $8 | $2.27 | +252.42% | 12 | Aug 14, 2026 | |
| VKTX Viking Therapeutics | Maintained: Buy | $100 | $34.36 | +191.04% | 35 | Aug 14, 2026 | |
| EQ Equillium | Maintained: Buy | $10 | $2.27 | +340.53% | 2 | Aug 14, 2026 | |
| BLTE Belite Bio | Maintained: Buy | $266 → $270 | $161.94 | +66.73% | 4 | Aug 14, 2026 | |
| CAMP Camp4 Therapeutics | Maintained: Buy | $7 | $4.46 | +56.95% | 8 | Aug 14, 2026 | |
| XNCR Xencor | Maintained: Buy | $44 | $27.00 | +62.96% | 5 | Aug 10, 2026 | |
| HROW Harrow | Maintained: Buy | $88 | $42.06 | +109.22% | 8 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $6 | $2.02 | +197.03% | 28 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $12.96 | +69.75% | 8 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $6.44 | +210.56% | 3 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $23.50 | +70.21% | 3 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $12 | $11.57 | +3.72% | 3 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26 → $29 | $9.66 | +200.21% | 4 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $46 | $36.39 | +26.41% | 6 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | kr 33.00 | kr 11.04 | +198.91% | 1 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $34 → $13 | $5.25 | +147.62% | 9 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.83 | - | 4 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | ¥1,130 | ¥281 | +302.14% | 1 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 → $49 | $27.78 | +76.39% | 3 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $250 | $229.30 | n/a | 1 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $15.86 | n/a | 1 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $93 → $103 | $143.44 | n/a | 35 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $2.94 | n/a | 10 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 → $17 | $5.75 | n/a | 4 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 → $51 | $109.51 | n/a | 2 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 → $56 | $25.98 | n/a | 5 | Jan 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $84 → $77 | $97.07 | n/a | 27 | Oct 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 → $17 | $1.19 | n/a | 4 | Jun 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 → $35 | $3.48 | n/a | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $94 → $78 | $12.44 | n/a | 15 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $38 | $121.50 | n/a | 1 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $519.09 | n/a | 6 | Dec 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $5 | $0.1575 | n/a | 2 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 | $56.69 | n/a | 1 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $10.99 | n/a | 11 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.56 | n/a | 10 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $7.02 | n/a | 4 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $214.35 | n/a | 16 | Jul 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $58.12 | n/a | 12 | Jun 13, 2021 |
Opus Genetics
Aug 21, 2026
Maintained: Buy
Price Target: $15
Current: $4.12
Upside: +264.08%
Innoviva
Aug 21, 2026
Maintained: Buy
Price Target: $34
Current: $21.00
Upside: +61.90%
EyePoint
Aug 17, 2026
Downgraded: Hold
Price Target: n/a
Current: $5.40
Upside: -
ProQR Therapeutics
Aug 14, 2026
Maintained: Buy
Price Target: $8
Current: $2.27
Upside: +252.42%
Viking Therapeutics
Aug 14, 2026
Maintained: Buy
Price Target: $100
Current: $34.36
Upside: +191.04%
Equillium
Aug 14, 2026
Maintained: Buy
Price Target: $10
Current: $2.27
Upside: +340.53%
Belite Bio
Aug 14, 2026
Maintained: Buy
Price Target: $266 → $270
Current: $161.94
Upside: +66.73%
Camp4 Therapeutics
Aug 14, 2026
Maintained: Buy
Price Target: $7
Current: $4.46
Upside: +56.95%
Xencor
Aug 10, 2026
Maintained: Buy
Price Target: $44
Current: $27.00
Upside: +62.96%
Harrow
Aug 10, 2026
Maintained: Buy
Price Target: $88
Current: $42.06
Upside: +109.22%
Aug 6, 2026
Maintained: Buy
Price Target: $4 → $6
Current: $2.02
Upside: +197.03%
Aug 6, 2026
Maintained: Buy
Price Target: $22
Current: $12.96
Upside: +69.75%
Aug 6, 2026
Maintained: Buy
Price Target: $20
Current: $6.44
Upside: +210.56%
Aug 6, 2026
Maintained: Buy
Price Target: $40
Current: $23.50
Upside: +70.21%
Aug 5, 2026
Reiterated: Buy
Price Target: $11 → $12
Current: $11.57
Upside: +3.72%
Jun 30, 2026
Maintained: Buy
Price Target: $26 → $29
Current: $9.66
Upside: +200.21%
Jun 29, 2026
Maintained: Buy
Price Target: $46
Current: $36.39
Upside: +26.41%
Jun 8, 2026
Initiated Coverage: Buy
Price Target: kr 33.00
Current: kr 11.04
Upside: +198.91%
May 18, 2026
Maintained: Buy
Price Target: $34 → $13
Current: $5.25
Upside: +147.62%
Apr 1, 2026
Maintained: Hold
Price Target: n/a
Current: $1.83
Upside: -
Mar 17, 2026
Initiated Coverage: Buy
Price Target: ¥1,130
Current: ¥281
Upside: +302.14%
Feb 19, 2026
Reiterated: Buy
Price Target: $42 → $49
Current: $27.78
Upside: +76.39%
Apr 28, 2025
Initiated Coverage: Hold
Price Target: $250
Current: $229.30
Upside: n/a
Dec 11, 2024
Maintained: Buy
Price Target: $22
Current: $15.86
Upside: n/a
Nov 8, 2024
Maintained: Buy
Price Target: $93 → $103
Current: $143.44
Upside: n/a
Nov 4, 2024
Downgraded: Hold
Price Target: n/a
Current: $2.94
Upside: n/a
May 10, 2024
Maintained: Buy
Price Target: $22 → $17
Current: $5.75
Upside: n/a
Apr 18, 2024
Maintained: Buy
Price Target: $24 → $51
Current: $109.51
Upside: n/a
Jan 3, 2024
Maintained: Buy
Price Target: $27 → $56
Current: $25.98
Upside: n/a
Oct 18, 2023
Maintained: Buy
Price Target: $84 → $77
Current: $97.07
Upside: n/a
Jun 23, 2023
Maintained: Buy
Price Target: $25 → $17
Current: $1.19
Upside: n/a
May 5, 2023
Maintained: Buy
Price Target: $33 → $35
Current: $3.48
Upside: n/a
May 5, 2023
Maintained: Buy
Price Target: $94 → $78
Current: $12.44
Upside: n/a
May 4, 2023
Upgraded: Buy
Price Target: $38
Current: $121.50
Upside: n/a
Dec 19, 2022
Upgraded: Hold
Price Target: n/a
Current: $519.09
Upside: n/a
Dec 7, 2022
Maintained: Buy
Price Target: $15 → $5
Current: $0.1575
Upside: n/a
Nov 9, 2022
Maintained: Buy
Price Target: $38
Current: $56.69
Upside: n/a
Aug 10, 2022
Downgraded: Sell
Price Target: n/a
Current: $10.99
Upside: n/a
May 18, 2022
Downgraded: Hold
Price Target: n/a
Current: $4.56
Upside: n/a
Aug 6, 2021
Maintained: Buy
Price Target: $18
Current: $7.02
Upside: n/a
Jul 22, 2021
Maintained: Hold
Price Target: n/a
Current: $214.35
Upside: n/a
Jun 13, 2021
Maintained: Sell
Price Target: n/a
Current: $58.12
Upside: n/a